Source: Υπουργείο Υγείας (CY) Revision Year: 2020 Publisher: ADL Pharmaceutical Products Ltd, 12 Agiou Spyridonos str., 7102 Aradippou, P.O. Box 40981, 6308 Larnaca, Cyprus, Tel.: 0035724667878
Nystalocal cream is indicated for the treatment of exudative inflammatory skin diseases which are microbiologically super infected particularly by Candida sp., such as diaper dermatitis, balanitis, vulvitis, anal eczema and intertriginous eczema.
Nystalocal cream is applied in a thin layer 2 to 3 times a day to skin and mucus membranes.
Special caution should be exercised when applying to infants and children (see Sections 4.4 and 4.8).
The clinical manifestations of Nystalocal overdosage correspond to the known overdosage of corticosteroids.
The manifestations mentioned under the paragraph “Undesirable effects” may occur more frequently.
21 months.
Do not store above 25°C.
Pack with one tube of Nystalocal cream 20 g.
Any unused medicinal product or waste material should be disposed of in accordance with local requirements.
© All content on this website, including data entry, data processing, decision support tools, "RxReasoner" logo and graphics, is the intellectual property of RxReasoner and is protected by copyright laws. Unauthorized reproduction or distribution of any part of this content without explicit written permission from RxReasoner is strictly prohibited. Any third-party content used on this site is acknowledged and utilized under fair use principles.
